Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 14
2004 5
2005 10
2006 4
2007 5
2008 10
2009 10
2010 6
2011 8
2012 11
2013 12
2014 14
2015 15
2016 32
2017 18
2018 22
2019 30
2020 39
2021 26
2022 15
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

304 results

Results by year

Filters applied: . Clear all
Page 1
Dengue.
Wilder-Smith A, Ooi EE, Horstick O, Wills B. Wilder-Smith A, et al. Lancet. 2019 Jan 26;393(10169):350-363. doi: 10.1016/S0140-6736(18)32560-1. Lancet. 2019. PMID: 30696575 Review.
Dengue vaccine development: status and future.
Wilder-Smith A. Wilder-Smith A. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):40-44. doi: 10.1007/s00103-019-03060-3. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 31784763 Free PMC article. Review.
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O'Brien KL, Smith PG, Wilder-Smith A, Zeger S, Deloria Knoll M, Patel MK. Feikin DR, et al. Among authors: wilder smith a. Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23. Lancet. 2022. PMID: 35202601 Free PMC article.
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.
Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H, Cheng B, Abu Raddad LJ, Buckeridge DL, Van Kerkhove MD, Piechotta V, Higdon MM, Wilder-Smith A, Bergeri I, Feikin DR, Arora RK, Patel MK, Subissi L. Bobrovitz N, et al. Among authors: wilder smith a. Lancet Infect Dis. 2023 May;23(5):556-567. doi: 10.1016/S1473-3099(22)00801-5. Epub 2023 Jan 18. Lancet Infect Dis. 2023. PMID: 36681084 Free PMC article.
Vaccines and therapeutics for immunocompromised patients with COVID-19.
Shoham S, Batista C, Ben Amor Y, Ergonul O, Hassanain M, Hotez P, Kang G, Kim JH, Lall B, Larson HJ, Naniche D, Sheahan T, Strub-Wourgaft N, Sow SO, Wilder-Smith A, Yadav P, Bottazzi ME; Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force. Shoham S, et al. Among authors: wilder smith a. EClinicalMedicine. 2023 May;59:101965. doi: 10.1016/j.eclinm.2023.101965. Epub 2023 Apr 12. EClinicalMedicine. 2023. PMID: 37070102 Free PMC article. Review.
Editorial overview: The challenge to defeat dengue.
Hiscott J, Wilder-Smith A. Hiscott J, et al. Among authors: wilder smith a. Curr Opin Virol. 2020 Aug;43:iii-v. doi: 10.1016/j.coviro.2020.10.004. Curr Opin Virol. 2020. PMID: 33160602 No abstract available.
Yellow Fever in Travelers.
Wilder-Smith A. Wilder-Smith A. Curr Infect Dis Rep. 2019 Oct 31;21(11):42. doi: 10.1007/s11908-019-0701-x. Curr Infect Dis Rep. 2019. PMID: 31673899 Review.
Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
Wilder-Smith A, Mulholland K. Wilder-Smith A, et al. N Engl J Med. 2021 Sep 2;385(10):946-948. doi: 10.1056/NEJMe2111165. N Engl J Med. 2021. PMID: 34469651 Free PMC article. No abstract available.
Dengue in travelers.
Wilder-Smith A, Schwartz E. Wilder-Smith A, et al. N Engl J Med. 2005 Sep 1;353(9):924-32. doi: 10.1056/NEJMra041927. N Engl J Med. 2005. PMID: 16135837 Review. No abstract available.
304 results